Literature DB >> 6216848

Immune regulation in myasthenia gravis: evidence for an increased suppressor T-cell population.

A E Miller, J Hudson, R S Tindall.   

Abstract

The production of anti-acetylcholine receptor antibodies in myasthenia gravis represents a persistent and unexplained break in self-tolerance. The studies reported here demonstrate an altered regulatory T-cell population with an increase in the percentage of circulating T-suppressor cells as defined by two independently developed murine monoclonal antibody markers. Leu 2a- and OKT8a-positive cells were significantly increased within the T-cell population in myasthenia gravis (25.0 +/- 6.4% versus 20.7 +/- 2.9% and 34.9 +/- 7.0% versus 26.0 +/- 3.2%, respectively) compared to an age- and sex-equivalent group. In addition, the circulating total T-cell population was reduced in myasthenia gravis. Patients with symptomatically uncontrolled disease (with or without immunosuppression) demonstrated significantly altered ratios of helper to suppressor T-cells, while patients whose myasthenia symptoms were controlled did not differ from normal subjects.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6216848     DOI: 10.1002/ana.410120405

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

Review 1.  Immunopathogenesis and treatment of myasthenia gravis.

Authors:  A I Levinson; B Zweiman; R P Lisak
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

Review 2.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

3.  A case of myasthenia gravis associated with optic neuritis.

Authors:  A Ghezzi; M Zaffaroni; D Caputo; A Zibetti; G Mariani
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

Review 4.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Pathogenesis of Mooren's ulcer: some new concepts.

Authors:  P I Murray; A H Rahi
Journal:  Br J Ophthalmol       Date:  1984-03       Impact factor: 4.638

6.  Acetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line.

Authors:  F Sinigaglia; C Gotti; R Castagnoli; F Clementi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions.

Authors:  D Safar; S Berrih-Aknin; E Morel
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

8.  Fetal alcohol syndrome and myasthenia gravis.

Authors:  M M Dahl-Regis; A Jayam-Trouth
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

9.  Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression.

Authors:  F Crosti; M Armanini; P Confalonieri; C Antozzi; R Mantegazza
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.